CBS 2019
CBSMD教育中心
中 文

Cardio-Oncology

Abstract

Recommended Article

ACS Management in a Patient in Need of Noncardiac Surgery Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort Study Cardiovascular effects of radiation therapy Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma Cardio-Oncology Services: rationale, organization, and implementation: A report from the ESC Cardio-Oncology council Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs

Review Article2018 Mar 13;137(11):1176-1191.

JOURNAL:Circulation Article Link

Exercise Therapy and Cardiovascular Toxicity in Cancer

Scott JM, Nilsen TS, Gupta D et al. Keywords: cardiorespiratory fitness; cardiotoxicity; exercise; heart failure; survivorship

ABSTRACT


Cardio-oncology is an emerging discipline focused predominantly on the detection and management of cancer treatment-induced cardiac dysfunction (cardiotoxicity), which predisposes to development of overt heart failure or coronary artery disease. The direct adverse consequences, as well as those secondary to anticancer therapeutics, extend beyond the heart, however, to affect the entire cardiovascular-skeletal muscle axis (ie, whole-organism cardiovascular toxicity). The global nature of impairment creates a strong rationale for treatment strategies that augment or preserve global cardiovascular reserve capacity. In noncancer clinical populations, exercise training is an established therapy to improve cardiovascular reserve capacity, leading to concomitant reductions in cardiovascular morbidity and its attendant symptoms. Here, we overview the tolerability and efficacy of exercise on cardiovascular toxicity in adult patients with cancer. We also propose a conceptual research framework to facilitate personalized risk assessment and the development of targeted exercise prescriptions to optimally prevent or manage cardiovascular toxicity after a cancer diagnosis.